Latest News about HRTX
Recent news which mentions HRTX
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 01, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Why Heron Therapeutics Shares Rose Nearly 15% This Week
December 09, 2021
Tickers
HRTX
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Falls Over 1%; Reata Pharmaceuticals Shares Plummet
December 09, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 09, 2021
From Benzinga
2 Short-Squeeze Candidates That Could Go Parabolic Soon
December 09, 2021
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Can These Former Biotech Growth Stocks Regain Their Form?
September 29, 2021
From Motley Fool
Heron Therapeutics's Return On Capital Employed Overview
September 21, 2021
Tickers
HRTX
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 13, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 09, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 04, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|
|
|
|